Form 8-K - Current report:
SEC Accession No. 0001104659-24-069083
Filing Date
2024-06-06
Accepted
2024-06-06 16:10:52
Documents
15
Period of Report
2024-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416537d1_8k.htm   iXBRL 8-K 28149
2 EXHIBIT 10.1 tm2416537d1_ex10-1.htm EX-10.1 39231
3 EXHIBIT 10.2 tm2416537d1_ex10-2.htm EX-10.2 38781
  Complete submission text file 0001104659-24-069083.txt   295630

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20240531.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20240531_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20240531_pre.xml EX-101.PRE 22372
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2416537d1_8k_htm.xml XML 3358
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 241025131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)